Klinic prescribes FDA-approved medications only, avoiding compounded versions to ensure safety and efficacy
Key takeaways Liraglutide is the active ingredient in the brand-name GLP-1 medications Saxenda and Victoza, while semaglutide is the active ingredient in Ozempic, Wegovy, and Rybelsus
[29] Patients should only access it through a registered clinical trial or under the direct supervision of an appropriately qualified healthcare professional
Obesity and cardiovascular risk: the new public health problem of worldwide proportions
In a head-to-head study (SURPASS-2), Mounjaro topped Ozempic (1 mg semaglutide), showing it was more effective in helping patients keep their blood sugar levels in check and lose weight
However, side effects of GLP-1 RAs, particularly those affecting the gastrointestinal system, may limit their use in patients with IBD